Salesforce, Inc. (CRM) Stock Price & How to Invest

Salesforce is the leading provider of cloud-based customer relationship management (CRM) software, helping companies manage sales, customer service, marketing, e-commerce, and analytics. Its core products include Sales Cloud, Service Cloud, Marketing Cloud, and Commerce Cloud, plus a broad platform for building custom applications. Through major acquisitions it also owns Slack (workplace collaboration), Tableau (data visualization and analytics), MuleSoft (data integration), and Informatica (data management), and it has pushed aggressively into artificial intelligence with its Einstein features and, more recently, Agentforce, a platform for deploying AI agents that automate sales, service, and other workflows. Salesforce makes money primarily through recurring subscription and support revenue, billed per user, giving it highly predictable, sticky software revenue at large scale. It is one of the largest enterprise software companies in the world, headquartered in San Francisco, and serves businesses of all sizes across virtually every industry globally. Over the twelve months to July 2026 it generated about $43.9 billion of revenue, about $9.7 billion of net income, and about $17.7 billion of free cash flow.

Salesforce's subscription growth has decelerated from its hyper-growth past to about 11-12%, and part of the current growth comes from the Informatica acquisition rather than organic demand, so the durability of reacceleration from AI is unproven. Enterprises are scrutinizing software budgets, lengthening sales cycles and pressuring seat-based growth, while a shift toward AI agents could even reduce the number of human seats customers buy. The market has priced that worry: the stock is down about 6% in 2026 and analysts expect EPS for the fiscal year ending January 2028 to dip about 4% after this year's jump. Competition is intense from Microsoft (Dynamics and Copilot), SAP, Oracle, ServiceNow, HubSpot, and AI-native startups. Acquisitions and the buyback have lifted total debt to about $42 billion against $11 billion of cash. Macro IT-spending weakness would directly pressure new bookings.

54 analysts publish price targets on CRM, averaging $285.68 against a $240.70 price as of October 2026, or +18.7%. The published targets run from $165.00 to $475.00, a wide spread, and the ratings split 40 buy, 15 hold, 1 sell. Over the last six months there have been 8 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CRM forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Salesforce, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Agentforce and AI monetization. Salesforce is positioning Agentforce, its platform for autonomous AI agents that handle customer service, sales, and other tasks, as a major new growth driver. The most optimistic published target, $475.00, assumes this works close to its best case.

The case against. Salesforce's subscription growth has decelerated from its hyper-growth past to about 11-12%, and part of the current growth comes from the Informatica acquisition rather than organic demand, so the durability of reacceleration from AI is unproven. The most pessimistic target, $165.00, is roughly what CRM is worth if this bites instead.

Read the full bull and bear case on CRM, including what would have to change to break either one. Walnut is not an investment adviser.

No. Salesforce, Inc. (CRM) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Salesforce, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$43.9 billion (fiscal Q2 2027 ~$11.35B, up ~11% YoY)
• Fiscal 2027 revenue guidance: $46.1-46.4 billion (11-12% growth), raised
• EPS: Fiscal Q2 2027 non-GAAP $5.90 vs $3.27 estimate (GAAP $4.29); FY2027 guidance $16.67-16.71
• Margins (TTM): Gross ~77%, operating ~21%
• Agentforce ARR: >$1.5 billion, up ~240% YoY; AI and data ARR ~$3.9 billion
• cRPO: ~$33.5 billion, up ~14% YoY in constant currency
• P/E: ~22x trailing, ~15x forward
• Market cap / dividend: ~$197 billion (shares ~$239, Oct 16, 2026); yield ~0.7% ($1.76 annual)

Salesforce no longer trades at a large software premium: about 15x forward earnings and 4.5x trailing sales, a lower multiple than many slower-growing industrial companies. The valuation balances a maturing growth profile and fears that AI agents erode seat-based pricing against fast-growing AI ARR, roughly $17.7 billion of trailing free cash flow and a $25 billion buyback. The next report (fiscal Q3 2027) is expected around December 2, 2026, with consensus EPS near $3.45 on ~$11.5 billion of revenue.

If you want CRM exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses CRM naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to CRM: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CRM exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (IGV, XLK, TECL), which spreads the position across many companies. Or build it into a focused thematic portfolio, so CRM sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CRM fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Salesforce (CRM) pairs a wide CRM moat and large subscription backlog with a pivot to profitability, free cash flow, buybacks, and a dividend, while betting on Agentforce AI to reaccelerate decelerating seat growth. The 2026 numbers show that bet starting to register: Agentforce ARR above $1.5 billion (up about 240% year over year), combined AI and data ARR near $3.9 billion, cRPO up 14% in constant currency, and fiscal 2027 guidance raised to $46.1-46.4 billion of revenue. At about 15x forward earnings, the stock is priced well below its old software premium. In a portfolio it is a large-cap quality-software and AI-optionality holding that competes with Microsoft, SAP, Oracle, and ServiceNow, carrying AI execution risk and the question of whether AI agents shrink seat-based demand.

Whether CRM is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CRM a buy or a sell?, and where the stock could go from here in the CRM stock forecast.

For income investors, whether CRM pays a dividend and how the payout looks is covered in does CRM pay a dividend? And to weigh CRM against a peer, read the full side-by-side comparisons: CRM vs MSFT and CRM vs GOOGL.